C21 Investments Inc. (CWLXF): Net Income

Annual figures by period end, from SEC filings.

-$3.24M
Year ended 2026-03-31
$9.95M2021-01-31: -$7.83M2022-01-31: $9.95M2023-01-31: $293.2K2024-01-31: -$3.31M2025-03-31: -$3.97M2026-03-31: -$3.24M-$3.24M
2021-01-31 Net Income (USD) 2026-03-31
Period endedNet IncomeChange YoYSource filing
2026-03-31-$3.24Mn/m2026-06-12, From 2025-04-01
2025-03-31-$3.97Mn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31-$3.31Mn/m2025-06-23, From 2023-02-01
2023-01-31$293.2K-97.1%2024-08-08, From 2022-02-01
2022-01-31$9.95Mn/m2023-07-28, From 2021-02-01
2021-01-31-$7.83Mn/a2023-07-28, From 2020-02-01

Net Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
C21 Investments Inc. (CWLXF)2026-03-31-$3.24Mn/m
Leef Brands Inc. (LEEEF)2025-12-31-$17.63Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$12.34Mn/m
Cyanotech Corp (CYAN)2025-03-31-$3.20Mn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31$4.50Mn/m
Bon Natural Life Ltd (BON)2025-09-30-$1.99Mn/m
Fitlife Brands, Inc. (FTLF)2025-12-31$6.33M-29.6%
Mannatech Inc (MTEX)2025-12-31-$15.21Mn/m
Niagen Bioscience, Inc. (NAGE)2025-12-31$17.38M+103.3%

Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗